Diabetes

The AJMC^® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Semaglutide injections | Image credit: Patrick Bay Damsted – stock.adobe.com

Semaglutide Lowers Risk of Major Kidney Outcomes, Cardiovascular Events, Death in Patients With Diabetes and CKD

By Hayden E. Klein

May 24th 2024

Patients who took the weekly glucagon-like peptide 1 (GLP-1) receptor agonist were 21% less likely to experience major kidney disease events and 29% less likely to die due to cardiovascular causes.

Supply of tirzepatide | Image credit: MKPhoto – stock.adobe.com

Most Insured Adults Still Have to Pay at Least Part of the Cost of GLP-1 Drugs

By Hayden E. Klein

May 16th 2024

Art Masturzo, MD, MBA

Dr Arti Masturzo Gives an In-Depth Look at CCS Survey Results Showing Misconceptions Around Diabetes Management

By Hayden E. Klein

May 6th 2024

Joanne Mizell

Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease

By Giuliana Grossi

May 1st 2024

Continuous glucose monitor | Image credit: habrovich – stock.adobe.com

Beyond Insulin: The Impact of Next-Generation Diabetes Technology

By Hayden E. Klein
Laura Joszt, MA

April 17th 2024

Continuing Medical Education

Continuing Medical Education

More News

October 10th 2011

The Incidence and Costs of Hypoglycemia in Type 2 Diabetes

Brian J. Quilliam, PhD Jason C. Simeone, PhD A. Burak Ozbay, PhD Stephen J. Kogut, PhD

The overall incidence of hypoglycemia was considerable in this large working-age population and was associated with $52 million (2008 dollars) in direct medical costs.

October 10th 2011

Evaluation of Value-Based Insurance Design With a Large Retail Employer

Yoona A. Kim, PharmD Aimee Loucks, PharmD Glenn Yokoyama, PharmD James Lightwood, PhD Karen Rascati, PhD Seth A. Serxner, PhD, MPH

Retrospective analysis of value-based insurance design (VBID) showed the potential for VBID to improve adherence and reduce utilization and costs with active disease management counseling.

October 7th 2011

Pharmacist-Provided Telephonic Medication Therapy Management in an MAPD Plan

Melea A. Ward, PharmD, MS Yihua Xu, PhD

Pharmacist-provided telephonic medication therapy management consultations can lead to decreases in total all-cause healthcare expenditures in a Medicare Advantage Prescription Drug plan population.

September 9th 2011

Predictive Model for Emergency Hospital Admission and 6-Month Readmission

Silvia Lopez-Aguila, MPH Joan Carles Contel, MPH Josep Farre, CIS Jose Luis Campuzano, MSTAT Luis Rajmil, PhD

Predictive models for hospital admissions and readmissions in persons aged >65 years have been developed through a combination of comorbidity and previous healthcare use.

September 7th 2011

Electronic Health Records, Clinical Decision Support, and Blood Pressure Control

Lipika Samal, MD, MPH Jeffrey A. Linder, MD, MPH Stuart R. Lipsitz, ScD LeRoi S. Hicks, MD, MPH

Physician use of EHRs with CDS is associated with increased blood pressure control and lower mean systolic blood pressure across US primary care visits.

September 6th 2011

Compliance, Persistence, and Switching Patterns for ACE Inhibitors and ARBs

Stefan Vegter, PharmD Nhu Ho Nguyen, MSc Sipke T. Visser, MSc Lolkje TW de Jong-van den Berg, PhD Maarten J. Postma, PhD Cornelis Boersma, PhD

This drug-utilization study in a prescription database of more than 50,000 patients analyzed compliance, persistence, and switching behavior for ACE inhibitors and ARBs.

September 6th 2011

Mental Illness and Warfarin Use in Atrial Fibrillation

Graham A. Walker, MD Paul A. Heidenreich, MD, MS Ciaran S. Phibbs, PhD Alan S. Go, MD Victor Y. Chiu, BA Susan K. Schmitt, PhD Lakshmi Ananth, MS Susan M. Frayne, MD, MPH

Atrial fibrillation patients with mental illness are less likely to receive warfarin anticoagulation; those who do receive warfarin have excess risk of over-anticoagulation.

August 9th 2011

Identifying Subgroups of Complex Patients With Cluster Analysis

Sophia R. Newcomer, MPH John F. Steiner, MD, MPH Elizabeth A. Bayliss, MD, MSPH

Cluster analysis can aid in identifying subgroups of patients with similar patterns of comorbid conditions for targeted care management.

August 9th 2011

Value-Based Purchasing: The Evidence

Gloria N. Eldridge, PhD, MSc Holly Korda, PhD, MA

A review of evidence about what works in 3 areas of value-based purchasing emphasized under healthcare reform: service delivery integration, payment, and value-based insurance design.

August 9th 2011

Classification of Health Plans Based on Relative Resource Use and Quality of Care

Sally E. Turbyville, MA, MS Robert C. Saunders, PhD Manasi A. Tirodkar, PhD, MS, Sarah H. Scholle, DrPh, MA L. Gregory Pawlson, MD, MPH

This study examines variation among health plans in resource use and quality of care for patients with diabetes mellitus or cardiovascular disease.

August 8th 2011

Diabetes and Employment Productivity: Does Diabetes Management Matter?

H. Shelton Brown III, PhD Adriana Perez, PhD Lisa Marie Yarnell, PhD Jose A. Pagan, PhD Craig L. Hanis, PhD, MS Susan P. Fisher-Hoch, MD Joseph B. McCormick, MD, MS

Diabetes itself affected working and wages more than control of blood sugar levels in a Mexican American population.

August 5th 2011

Comparative Efficacy of Ezetimibe/Simvastatin, Rosuvastatin, and Atorvastatin in Uncontrolled Hyperlipidemia Patients

Amy Furman, PharmD Joy L. Meier, PharmD Robert A. Malmstrom, PharmD Julio R. Lopez, PharmD Saul Schaefer, MD

Efficacy of switching statin therapy from generic simvastatin was examined in a VA population. Ezetimibe/simvastatin was more potent than atorvastatin or rosuvastatin in lowering LDL.

July 14th 2011

Obtaining Patient Feedback at Point of Service Using Electronic Kiosks

Danae N. DiRocco, MPH Susan C. Day, MD, MPH

Electronic kiosks were used to survey patients on their experience with care at the time of care delivery in an urban primary care practice.

July 14th 2011

Addressing Healthcare Inequities in Israel by Eliminating Prescription Drug Copayments

Asher Elhayany, MD, MPA Shlomo Vinker, MD

In this prospective cohort study, eliminating prescription drug copayments improved blood pressure and LDL cholesterol concentration for low-income patients; glycemic control did not improve.

July 13th 2011

Systolic Blood Pressure Control After Participation in a Hypertension Intervention Study

Lesley K. Welch, PharmD Kari L. Olson, PharmD Karen E. Snow, Lauren Pointer, MS Anne Lambert-Kerzner, MSPH Edward P. Havranek, MD David J. Magid, MD, MPH P. Michael Ho, MD, PhD

Systolic blood pressure control was not maintained in a large proportion of patients after the end of participation in a hypertension intervention study.

June 23rd 2011

Telehealth and Hospitalizations for Medicare Home Healthcare Patients

Hsueh-Fen Chen, PhD M. Christine Kalish, MBA, CMPE Jose A. Pagan, PhD

An integrated, clinician-focused telehealth monitoring system significantly reduced hospitalizations in Medicare home healthcare patients.

June 22nd 2011

Shared Medical Appointments in a Residency Clinic: An Exploratory Study Among Hispanics With Diabetes

Natalia Gutierrez, MD Nora E. Gimpel, MD Florence J. Dallo, PhD, MPH Barbara M. Foster, PhD Emeka J. Ohagi, PhD, MPH

This article evaluates and compares the effectiveness of shared medical appointments versus regular office visits among Hispanic patients with diabetes.

June 17th 2011

Identifying Favorable-Value Cardiovascular Health Services

R. Scott Braithwaite, MD, MS Sherry M. Mentor, MPH

Health improvements are usually expensive. If healthcare does not encourage high-value care and discourage low-value care, insurance premiums will continue to outpace inflation.

June 16th 2011

Better Continuity of Care Reduces Costs for Diabetic Patients

Chi-Chen Chen, PhD Shou-Hsia Cheng, PhD

This longitudinal analysis of diabetes patients found that better continuity of care was associated with reduced healthcare utilization and decreased pharmaceutical and total healthcare expenses.

June 14th 2011

Disease Management Programs in Type 2 Diabetes: Quality of Care

Heiner K. Berthold, MD, PhD Kurt P. Bestehorn, MD Christina Jannowitz, MD Wilhelm Krone, MD Ioanna Gouni-Berthold, MD

Disease management programs for diabetes can improve some processes of care, but they do not improve intermediate outcomes beyond doubt.

May 23rd 2011

Identification of Patients Likely to Benefit From Care Management Programs

Tobias Freund, MD Cornelia Mahler, MA, RN, PhD Antje Erler, MD, MPH Jochen Gensichen, MD, MA, MPH Dominik Ose, DrPH, MPH Joachim Szecsenyi, MD, MSc Frank Peters-Klimm, MD

Three approaches to prospective patient identification for care management programs were compared: predictive modeling, selection by primary care physician, and a combination of both.

May 21st 2011

Adherence to Laboratory Test Requests by Patients With Diabetes: The Diabetes Study of Northern California (DISTANCE)

Howard H. Moffet, MPH Melissa M. Parker, MS Urmimala Sarkar, MD, MPH Dean Schillinger, MD Alicia Fernandez, MD Nancy E. Adler, PhD Alyce S. Adams, PhD Andrew J. Karter, PhD

Providers expect that patients with chronic conditions will complete necessary laboratory tests; 1 in 7 patients with diabetes did not do so within 6 months.

April 19th 2011

Relevance of Current Guidelines for Organizing an Anticoagulation Clinic

Adam J. Rose, MD, MSc Elaine M. Hylek, MD, MPH Al Ozonoff, PhD Arlene S. Ash, PhD Joel I. Reisman, AB Patricia P. Callahan, RPh Margaret M. Gordon, PharmD Dan R. Berlowitz, MD, MPH

Anticoagulation clinics in an integrated healthcare system differed widely in their organization and management, but these differences were not consistently related to their performance.

April 19th 2011

Primary Care and Communication in Shared Cancer Care: A Qualitative Study

Yvonne H. Sada, MD Richard L. Street Jr, PhD Hardeep Singh, MD, MPH Rachel E. Shada, MHR Aanand D. Naik, MD

This qualitative study assesses patient, PCP, and oncologist views on primary care roles in shared cancer care, as well as patterns of communication between physicians.

April 13th 2011

A Multimodal Blood Pressure Control Intervention in 3 Healthcare Systems

David J. Magid, MD, MPH P. Michael Ho, MD, PhD Kari L. Olson, BSc (Pharm), PharmD David W. Brand, MSPH Lesley K. Welch, PharmD Karen E. Snow, PharmD Anne C. Lambert-Kerzner, MSPH Mary E. Plomon

A multisite multimodal intervention of patient education, home monitoring, measurement reporting to an IVR system, and pharmacist follow-up achieved greater BP reductions vs usual care.

March 28th 2011

HIT Interventions to Improve Diabetes and Cardiovascular Medication Adherence

William Shrank, MD

Dr. William Shrank, Harvard Medical School, Brigham and Women's Hospital, discusses his paper and answers questions at the National Press Club in Washington, DC.

March 23rd 2011

Liraglutide: A Review of the First Once-Daily GLP-1 Receptor Agonist

Bruce Bode, MD, FACE

March 23rd 2011

Differentiating Incretin-Based Therapies for Population-Based Health Care

David Calabrese, RPh, MHP

March 23rd 2011

Application of Comparative Effectiveness Research in Evaluation of Treatments for Type 2 Diabetes Mellitus

Andrew Ahmann, MD

March 23rd 2011

Introduction: Evaluating the Role of Incretin-Based Therapies in the Management of Type 2 Diabetes

...

90 91 92 93 94 95 96 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions